Skip to main content

View full-text article in PMC

. 2018 Feb 1;25(2):111–123. doi: 10.5551/jat.RV17016

Table 3. Circulating cathepsins in patients with coronary artery disease, AAA, adiposity, PAD, or coronary artery calcification.

Disease	CatS	CatK	CatL	Cystatin C
Coronary artery disease	Increase^{88, 89)}	Increase⁹⁰⁾	Increase²²⁾	Increase⁸⁹⁾ Decrease⁴²⁾
AAA	Increase^{92, 93)}	–	–	Decrease^{33, 92, 94)}
Adiposity	Increase^{95, 96)}	–	–	–
PAD	–	–	–	Increase⁹⁷⁾
Coronary artery calcification	–	Increase (in non-diabetic patients with CKD)⁹⁹⁾	–	–

CatS indicates cathepsin S; CatK, cathepsin K; CatL, cathepsin L; AAA, abdominal aortic aneurysms; PAD, peripheral arterial disease; CKD, chronic kidney disease.